BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 25586444)

  • 1. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
    Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
    Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
    Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
    Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
    Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Qian W; Huang GZ
    Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
    Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
    Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
    Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
    Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
    Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis.
    Kocazeybek B; Küçükoğlu S; Oner YA
    Chemotherapy; 2003 May; 49(1-2):76-84. PubMed ID: 12714816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
    Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
    Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin in children admitted to hospital with community acquired pneumonia.
    Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
    Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil CD64 Expression as a Diagnostic Marker in Patients Hospitalized with Exacerbations of COPD: A Prospective Observational Study.
    Titova E; Aune MW; Fonn K; Henriksen AH; Åsberg A
    Lung; 2015 Oct; 193(5):717-24. PubMed ID: 26174093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
    Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.